Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 3, 2008, Pages 283.e1-283.e8

  Katz, Leila ^a   de Amorim, Melania Maria Ramos ^a,b   Figueiroa, José Natal ^a   e Silva, João Luiz Pinto ^b  

^a Departments of Obstetrics and Gynecology   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

dexamethasone; hemolysis, elevated liver enzymes, and low platelets syndrome; postpartum; randomized controlled trial

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CAPTOPRIL; DEXAMETHASONE; HEPARIN; HYDROCHLOROTHIAZIDE; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; PLACEBO; PROPRANOLOL; RINGER LACTATE SOLUTION;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HELLP SYNDROME; HEMOGLOBIN DETERMINATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

EID: 39649108205     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.10.797     Document Type: Article

References (29)

1. Sibai B.M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol 162 (1990) 311-316
2. Maggann E.F., and Martin Jr. J.N. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 42 (1999) 532-550
3. Santos LC, Amorim MMR, Katz L, Albuquerque CJM. Terapia Intensiva em Obstetrícia, Rio de Janeiro: Medsi; 2004. Capítulo 5:63-75.
4. Thiagarajah S., Bourgeois F.J., Harbert Jr. G.M., and Caudle M.R. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 150 (1984) 1-7
5. Yalcin O.T., Sener T., Hassa H., Ozalp S., and Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynecol Obstet 61 (1998) 141-148
6. Suresh M.S. HELLP syndrome: an anesthesiologist's perspective. Anesth Clin North Am 16 (1998) 332-348
7. O'Brien J.M., Shumate S.A., Satchwell S.L., Milligan D.A., and Barton J.R. Maternal benefit of corticosteroids therapy in patients with HELLP (hemolysis, elevated liver enzymes and low platelets count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 186 (2002) 475-479
8. Mecacci F., Carignani L., Cioni R., et al. Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone. Thromb Res 102 (2001) 99-105
9. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., and Friedman S.A. Maternal-morbidity and mortality in 442 pregnacies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 (1993) 1000-1006
10. Martin Jr. J.N., Files J.C., Blake P.G., et al. Plasma exchange for preeclampsia. I. Postpartum use for persistent severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol 162 (1990) 128-137
11. Martin Jr. J.N., Files J.C., Blake P.G., Perry Jr. K.G., Morrison J.C., and Norman P.H. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 172 (1995) 1107-1127
12. Magann E.F., Bass D., Chauhan S.P., Sullivan D.L., Martin R.W., and Martin Jr. J.N. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 171 (1994) 1148-1153
13. Vigil-De Gracia P.E., and García-Cáceres E. Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynecol Obstet 59 (1997) 17-22
14. Fonseca J.E., Mendez F., Catano C., and Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 (2005) 1591-1598
15. Martin Jr. J.N., Perry Jr. K.G., Blake P.G., May W.A., Moore A., and Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 177 (1997) 1011-1017
16. Tompkins M.J., and Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 181 (1999) 304-309
17. Varol F., Aydin T., and Gücer F. HELLP syndrome and postpartum corticosteroids. Int Gynaecol Obstet 73 (2001) 157-159
18. Isler C.M., Barrillleaux P.S., Magann E.F., Bass J.D., and Martin Jr. J.N. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Am J Obstet Gynecol 184 (2001) 1332-1339
19. Matchaba P., and Moodley J. Corticosteroids for HELLP syndrome in pregnancy (Cochrane Review). The Cochrane Library, Issue 4 (2004), Update Software, Oxford
20. Zuspan F.P. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 9 (1966) 954-972
21. Bouchnak M., Souissi K., Ouragini H., Abbes Z., Douiri H., and Maghrebi H. Intérêt de la corticothérapie en post partum dans le HELLP (hemolysis elevated liver enzymes low platelets count) syndrome. Tunis Med 83 (2005) 473-476
22. Roberts W.E., Perry Jr. K.G., Woods J.B., Files J.C., Blake P.G., and Martin Jr. J.N. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications?. Am J Obstet Gynecol 171 (1994) 799-804
23. Haddad B., Barton J.R., Livingston J.C., Chahine R., and Sibai B. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation. Am J Obstet Gynecol 183 (2000) 1475-1479
24. Nunes F., Campos A.P., Avillez T., Rodrigues R., and Meirinho M. Corticosteroid therapy for patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Acta Med Port 18 (2005) 177-182
25. van Runnard Heimel P.J., Huisjes A.J., Franx A., Koopman C., Bots M.L., and Bruinse H.W. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 128 (2006) 187-193
26. O'Brien. Dexamethasone, HELLP syndrome, and study design. Am J Obstet Gynecol 195 (2006) 13-14
27. Fonseca J.E., Arias F., and Mendez F. Dexamethasone, HELLP syndrome, and study design. Am J Obstet Gynecol 195 (2006) 15-17
28. Martin Jr. J.N., Rose C.H., and Briery C.M. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195 (2006) 914-934
29. Rychel V., and Williams K.P. Correlation of platelet count changes with liver cell destruction in HELLP syndrome. Hypertens Pregnancy 22 (2003) 57-62